Group items tagged

Leaders of speciality clinical chemistry reagents manufacturers - protonbiologicals are well reputed industrialists in biomedical. Our products are firm up to expiry date - even after opening the envelop, anytime usable, many with no measure reagent preparation. Our economical friendly reagent kits are manufactured to meet the desires of small scale or large scale laboratories. Reconstitution errors and water contamination are avoided which yields guaranteed results. Our main motto is to provide responsive, high-quality, cost-effective, comprehensive diagnostic kits and reagents for blood analysis which meet our customers' expectations.

Protonbiologicals, tagged as one of the best clinical chemistry reagents manufacturers, stands out among the best reagent producers. Chemists in the protonbiologicals use various analytical techniques such as spectrophotometry, molecular diagnostics, electrophoresis and measurement of enzyme activities.

Protonbiologicals - the ADA kits Manufacturers are global leaders in manufacturing diagnostic kits. We also offers products in the areas of Serology, Clinical Chemistry, Turbidometry, Rapid Tests, ELISA, Chemiluminescence, Immunofluorescence, Biomedical Equipments and allied services such as development of customized technologies for the important customers, OEM Bulk supplies for manufacturing companies.

Global drug discovery services market will continue to grow, owing to upsurge in externalization of R&D activities, rising expenditure on R&D, and increasing incidence of chronic diseases. Expiration of patents boosting the demand for drug discovery and the introduction of innovative drug discovery technologies are projected to support the market growth during the forecast period 2019-2025. The global drug discovery services market, by type, is segmented into medicinal chemistry services, biology services, and pharmacokinetics and drug metabolism. Among these, the medicinal chemistry services segment accounted for the largest share in 2018 and is expected to grow at a high-double-digit CAGR by 2025. Increasing tendency of pharma companies to externalize discovery & development services, upsurge in the number of drug discovery & development activities, and growing R&D expenditure are the key factors driving the growth of the segment.

Protonbiologicals was started in early 2011 with a clear mission of manufacturing better quality diagnostic kits in customer friendly way. Research and development team of Diagnostic kits manufacturers has always been succeeded to set up a trial that helps recognize disease in very effective manner. Our expert team knows very well that diagnostic trial plays a crucial role in successful patient management which is why diagnostic assay is been our one of high prioritized phase in the process.

The factors such as single treatment for minor or simple infections, inadequate infrastructures, and disinclination for the treatment in retail clinics are the factors that hinder the growth potential of the market. North America has the largest share in the retail clinics market to date, this is because of the preference of the retail clinic as they are a highly efficient and cost-effective market. Whereas Europe is continuously growing which is due to the growing emphasis on preventive care and direct hospitalization.